Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When ...

It was one of the Danish pharma giant's worst days on the stock market, as its shares fell by up to 29 per cent. The company ...

A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the ...

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.

Ozempic, Wegovy and Mounjaro featured prominently. Known for their use in managing type 2 diabetes and aiding weight loss for ...

in a blow to attempts to release a successor to Wegovy - Staff/Victoria Klesty Shares in Novo Nordisk have fallen by more than a quarter after the Ozempic maker revealed a set of underwhelming ...

Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a takeover of US health products manufacturer Catalent, in a deal worth $11. ...